Lazarus Pharmaceuticals, LLC is a biopharmaceutical company
utilizing an asset-centric business model of independent portfolio companies
focused on maximizing the value of each asset. The assets we develop will address
under served needs in gastroenterology and other select therapeutic areas where we can
achieve significant advances in patient quality of life. Our experienced management team is
highly qualified to both identify and develop these assets while providing significant returns for our investors.